Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00298623
Status:
COMPLETED
Last Update Posted:
2013-05-14
First Post:
2006-02-28
Brief Title:
XP13512 GSK1838262 Versus Placebo in Patients With Restless Legs Syndrome
Sponsor:
XenoPort Inc
Organization:
XenoPort Inc
Organization Data
Organization:
XenoPort Inc
Class:
INDUSTRY
Study ID:
110963
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
XenoPort Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Cheri Hudson Clinical Disclosure Advisor
Old Organization:
GSK Clinical Disclosure